Kozak KR et al. |
Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. |
2000 |
J. Biol. Chem. |
pmid:10931854
|
Jarrahian A et al. |
Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter. |
2000 |
J. Neurochem. |
pmid:10820223
|
Gonsiorek W et al. |
Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. |
2000 |
Mol. Pharmacol. |
pmid:10779390
|
Beltramo M and Piomelli D |
Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. |
2000 |
Neuroreport |
pmid:10817598
|
Maccarrone M et al. |
Anandamide and 2-arachidonoylglycerol inhibit fatty acid amide hydrolase by activating the lipoxygenase pathway of the arachidonate cascade. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:11095952
|
Calignano A et al. |
A role for the endogenous cannabinoid system in the peripheral control of pain initiation. |
2000 |
Prog. Brain Res. |
pmid:11098711
|
Di Marzo V et al. |
Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. |
2000 |
J. Neurochem. |
pmid:11080195
|
Howlett AC and Mukhopadhyay S |
Cellular signal transduction by anandamide and 2-arachidonoylglycerol. |
2000 |
Chem. Phys. Lipids |
pmid:11106782
|
Martin BR et al. |
Cannabinoid properties of methylfluorophosphonate analogs. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10945879
|
Hillard CJ |
Endocannabinoids and vascular function. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10871291
|
Di Marzo V et al. |
Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide. |
2000 |
Eur. J. Pharmacol. |
pmid:11040343
|
Szallasi A and Di Marzo V |
New perspectives on enigmatic vanilloid receptors. |
2000 |
Trends Neurosci. |
pmid:11006466
|
Kurihara J et al. |
2-Arachidonoylglycerol and anandamide oppositely modulate norepinephrine release from the rat heart sympathetic nerves. |
2001 |
Jpn. J. Pharmacol. |
pmid:11676206
|
van der Stelt M et al. |
Exogenous anandamide protects rat brain against acute neuronal injury in vivo. |
2001 |
J. Neurosci. |
pmid:11698588
|
Hansen HH et al. |
Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration. |
2001 |
J. Neurochem. |
pmid:11579150
|
Wagner JA et al. |
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. |
2001 |
J. Am. Coll. Cardiol. |
pmid:11738314
|
Sugiura T et al. |
Rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain after decapitation. |
2001 |
Neurosci. Lett. |
pmid:11137756
|
Panikashvili D et al. |
An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. |
2001 |
Nature |
pmid:11586361
|
Savinainen JR et al. |
Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes. |
2001 |
Br. J. Pharmacol. |
pmid:11588122
|
Suhara Y et al. |
Synthesis and biological activities of novel structural analogues of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. |
2001 |
Bioorg. Med. Chem. Lett. |
pmid:11454463
|